Skip links

Quick Updates

Happy Chinese New Year from QuarkBio!

Happy Chinese New Year from QuarkBio! We're looking forward to a prosperous Year of the Pig as PanelStation™ reception in China has been overwhelmingly positive, as it allows users to translate research findings into ready-to-use products in clinical settings. Additionally, plans to obtain ISO13485 certification

Happy Holidays from Quark Biosciences!

We have officially launched our PanelStation™ V1.0! Our Christmas miracle will be sailing across the Taiwan strait in January to different locations in China where we will be translating discoveries into clinical diagnostic products with local researchers. We aim to develop a series of precision

Wishing everybody a Happy Thanksgiving from QuarkBio!

We are thankful this year for the development contract signed this week with Amwise Diagnostics to develop RecurIndex® (the only Asian-specific breast cancer treatment selection panel on the market) using QuarkBio's PanelChip® Analysis System. Together, we will enter the Chinese market, starting with a clinical

Happy Halloween!

Happy #Halloween from Quark Biosciences! Remember, you're never too old to beg for free treats, so come ask us for your interesting #miRNA fact today! #miHalloweenTreat

Using Expression Biomarkers to Improve Pediatric Cancer Care

While not as prevalent as other cancer diseases, every day, 43 children are diagnosed with cancer. Children’s cancer affects all ethnic, gender and socio-economic groups and more than 40,000 children undergo treatment for cancer each year. 12% of children diagnosed with cancer do not survive,

A Novel Multi-Gene Detection Platform for the Analysis of miRNA Expression

QuarkBio’s newest publication demonstrates the use of QuarkBio’s PanelChip™ Analysis System as a powerful technology for discovering and validating extracellular miRNA cancer biomarkers. By analyzing miRNA levels in the plasma, we were able to discover miRNA expression patterns capable of separating healthy subjects from patients with oral

New Collaboration With Min-Sheng General Hospital

QuarkBio has partnered with Min-Sheng General Hospital, one of the top hospitals in Taiwan, to implement an early stage cancer detection tool for multiple types of cancer. Min-Sheng General Hospital will be providing 1,000 clinical samples as a trial run before providing the detection test as
Close Bitnami banner